Mar 24, 2025 · Spevigo (also known by its generic name spesolimab-sbzo) is a biologic medication that was approved in 2022 for the treatment of adults with generalized pustular …

Aug 29, 2025 · Spevigo (spesolimab) is used to treat generalized pustular psoriasis (GPP) in adults and children 12 years and older who weigh at least 88 pounds (40 kg). This monoclonal …

Get to know Spevigo® (spesolimab-sbzo) injection. SPEVIGO is a prescription medicine used to treat generalized pustular psoriasis (GPP) in adults and children 12 years of age and older …

SPEVIGO is an interleukin-36 receptor antagonist indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and …

Aug 2, 2024 · Abstract Spevigo ® (spesolimab-sbzo) injection was recently approved for the treatment of generalized pustular psoriasis (GPP) in adults aged 18- 75 years. Spesolimab, a …

Mar 21, 2024 · FDA Expands Approval of SPEVIGO ® for Generalized Pustular Psoriasis SPEVIGO ® is now approved to treat GPP in adults and children aged 12 and above.

Find recommended dosing information of Spevigo® to treat Generalized Pustular Psoriasis (GPP). See ISI, PI & Med Guide.

Mar 17, 2023 · Spevigo is a prescription infusion that treats generalized pustular psoriasis flares in adults. Learn about cost, dosage, how it works, and more.

Jan 16, 2025 · Spevigo (spesolimub-sbz) is commonly used to treat generalized pustular psoriasis, which is a type of skin condition that causes skin bumps with pus (pustules).

Aug 5, 2024 · Spevigo (spesolimab or spesolimab-sbzo) treats generalized pustular psoriasis (GPP) in people ages 12 years and older. This medication is a biologic that's called an …